Cracking Europe: Pairwise Licenses CRISPR Tech to Rainbow Crops

DURHAM, N.C., and GHENT, Belgium – October 08, 2026 – Innovation in agriculture rarely happens in a vacuum; it happens in the dirt, bounded by the hard realities of regulation, biology, and the weather. For decades, the European Union has operated as a regulatory fortress, largely impenetrable to agricultural biotechnology. But with a seismic legislative shift looming on the horizon, the race to execute is officially on.

Today’s announcement that U.S.-based gene-editing powerhouse Pairwise is licensing its proprietary Fulcrum® platform to Belgian agtech startup Rainbow Crops is more than a standard technology transfer. It is a calculated, transatlantic maneuver to capture the impending European market for climate-resilient row crops. Rainbow Crops will integrate the Fulcrum CRISPR toolbox into its Trait Foundry™ platform, expanding its editing capabilities across internal crop programs and global collaborations.

For leaders tracking the intersection of emerging tech and commercial execution, this deal offers a masterclass in strategic positioning. It highlights how established CRISPR toolkits and AI-driven trait platforms are converging to rapidly bring climate-resilient row crops to market before the regulatory gates fully open.

Unlocking Fortress Europe

To understand the timing of this partnership, one must look at Brussels. In June 2026, the European Parliament formally adopted the New Genomic Techniques (NGT) regulation, effectively rewriting the rules of engagement for agricultural biotech on the continent. Entering into force this past July, the framework establishes a critical two-year runway before its application date in July 2028.

Under the new rules, Category 1 NGT plants—those with genetic modifications that could theoretically occur naturally or through conventional breeding—will be exempt from stringent legacy GMO legislation and consumer-facing GMO labeling. While seed and reproductive material will still require an NGT-1 identification tag, the pathway to commercialization has been drastically simplified.

"The agreement comes as Europe opens the door to precision breeding," the companies noted in their joint release. But the underlying business reality is entirely about timelines. Seed development is not consumer software; you cannot code a drought-resistant corn hybrid in a weekend and push an update on Monday. To have commercial varieties ready for field trials and regulatory verification when the new rules apply in 2028, companies must be editing, phenotyping, and validating today. By integrating Pairwise’s established CRISPR toolbox into its operations now, the Belgian startup is buying time—the single most valuable commodity in agricultural technology.

AI Meets CRISPR: The Multiplex Imperative

For years, the gene-editing narrative was dominated by single-gene knockouts—simple edits for simple traits. But the execution phase of modern agriculture demands solutions to polygenic challenges like extreme heat, prolonged drought, and devastating floods. Tackling these issues requires multiplex editing: the ability to make multiple, precise edits simultaneously across a plant's genome without triggering unintended off-target effects.

Rainbow Crops brings its Trait Foundry™ platform to the table, a system that integrates artificial intelligence, precision breeding, and automated phenotyping to systematically engineer these complex agronomic traits. "Building Fulcrum into Trait Foundry gives us additional tools to pursue complex traits and strengthens what we can bring to the seed and breeding partners we work with," said Giacomo Bastianelli, Co-founder and CEO of Rainbow Crops. "As more markets embrace modern breeding technologies, the opportunity is to move useful traits into farmers’ hands faster."

Pairwise’s Fulcrum platform acts as the execution engine for Rainbow’s AI-driven trait discovery. By bundling multiple editing technologies under a single license, Fulcrum allows the startup to move from predictive models to physical prototypes with unprecedented speed and reliability.

"Fulcrum has already demonstrated its ability to perform in AI-enabled multiplex editing programs, including across Pairwise’s own crop programs," noted Tom Adams, CEO of Pairwise. "That proven capability is increasingly important as crop development becomes more focused on complex, multi-trait challenges."

From Academic Spinoff to Global Contender

The rapid ascent of Rainbow Crops highlights a maturing European agtech ecosystem. Founded just last year in 2025 as a spin-off from the VIB-UGent Center for Plant Systems Biology, the company has quickly transitioned from publicly funded academic research to a venture-backed commercial player.

This trajectory is not accidental. European research institutions are increasingly prioritizing tech transfer, building commercial engines capable of competing on a global scale. Rainbow Crops recently closed an oversubscribed €9.7 million seed funding round, drawing investment from major industry players like Corteva through its Corteva Catalyst platform. Bolstered by a separate $7 million grant from the Gates Foundation targeting heat and drought resistance in sorghum and rice, the startup is proving that European innovation can attract serious capital and tackle global food security challenges.

Securing the Fulcrum license is the next logical step in this evolution. It bridges the gap between proprietary trait discovery and commercial-scale genetic engineering, allowing the company to punch above its weight class when negotiating with global seed partners.

The Competitive Landscape of Crop Design

The Pairwise-Rainbow alliance does not exist in a vacuum. The agricultural CRISPR landscape is becoming fiercely competitive as legacy giants and nimble startups vie for market share. Companies like Bayer are heavily integrating genome editing with AI to accelerate internal product development, aiming to launch edited corn and soy lines in the early 2030s. Meanwhile, Corteva offers non-exclusive licenses to its CRISPR-Cas9 technology, scaling financial terms based on the licensee's size, and innovators like Inari Agriculture are pushing forward with proprietary predictive design platforms.

Pairwise has differentiated itself through a broad, non-exclusive licensing model, positioning Fulcrum as a comprehensive toolkit for gene editing. With 25 licensees now covering over 30 species, the North Carolina company is effectively building an ecosystem around its proprietary technology. By arming startups like Rainbow Crops, Pairwise expands its footprint and revenue streams without bearing the localized risk of European field trials and seed commercialization.

For agribusiness leaders, the takeaway is clear: the era of isolated, proprietary walled gardens in early-stage trait development is giving way to strategic, cross-border platform licensing. As AI identifies the necessary genetic tweaks and CRISPR provides the molecular scissors, the bottleneck shifts from biological discovery to operational execution.

The companies that can effectively bridge that gap—combining advanced trait prediction with reliable, multiplex editing capabilities—will dictate the future of climate-resilient agriculture. With the 2028 European deregulation deadline ticking closer, partnerships like this one are no longer just speculative bets. They are the operational blueprints for the next decade of global farming, proving once again that in the business of disruption, execution is the only metric that truly matters.